Spencer Egan

Spencer Egan has a diverse work experience in business development and solutions. Spencer currently holds the position of Director of Business Development at uMotif since 2024. Prior to that, they served as the Global Head of Business Development and Solutions at Reveles Clinical Services from 2022 to 2024. Additionally, they held the role of Co-Leader in the Diversity, Equity & Inclusion in Digitized Clinical Trials Initiative at Digital Medicine Society (DiMe) from 2022 to 2023. From 2018 to 2021, Spencer worked at Signant Health as the Senior Director & Global Team Lead for Solutions Sales. Spencer also gained experience at Medidata Solutions as a Solutions Consultant, Sales SME, and later as a Business Development Specialist from 2014 to 2018. Before that, they worked as a Business Development Lead in Biotech Manufacturing at Scantibodies Laboratory, Inc. from 2012 to 2013. Additionally, Spencer was a Committee Member at the Association of Clinical Research Organizations (ACRO) from 2020 to 2021.

Spencer Egan holds a Bachelor of Arts (B.A.) degree in International Politics - National Security Studies from Penn State University.